The Angeles Clinic and Research Institute| May 21, 2026

Advances in Melanoma Care: A Multidisciplinary Symposium

Host: The Angeles Clinic and Research Institute (A Cedars-Sinai Affiliate)
Date: Thursday, May 21, 2026 Time: 4:00 PM PT / 5:00 PM MT / 6:00 PM CT / 7:00 PM ET

This symposium brings together leading melanoma specialists from The Angeles Clinic, Memorial Sloan Kettering, and Massachusetts General Hospital for a comprehensive afternoon program covering the full spectrum of melanoma care — from surgical and adjuvant approaches through cutting-edge cellular and targeted therapies, with dedicated patient resources and a Q&A session to close.

The program features a strong multidisciplinary lineup — combining medical oncology, surgical oncology, and cellular therapy expertise — anchored by The Angeles Clinic team (Drs. Hamid, Mehmi, Fischer, and Faries) with national experts from MSK (Dr. Smithy) and Mass General (Dr. Sullivan), plus patient-advocacy representation from AIM at Melanoma.

Key Themes Covered

  • Treatment sequencing: Adjuvant and neoadjuvant strategies, both medical and surgical
  • Immunotherapy frontier: T-cell therapies and first-line systemic options
  • Precision medicine: Targeted therapies for actionable mutations
  • Special populations: Uveal melanoma and other rare subtypes
  • What’s next: Novel and emerging therapeutics
  • Patient support: Community resources via AIM at Melanoma

The symposium runs approximately 2 hours 40 minutes, concluding with an open Q&A for attendees.


Presenters & Topics

4:00 PM PT

Welcome and Introductions
Omid Hamid, MD
Co-Director of Cutaneous Oncology
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate

4:10 PM PT

Adjuvant/Neo Adjuvant Therapeutic Considerations
Inderjit Mehmi, MD
Medical Oncologist
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate

4:30 PM PT

(Neo) Adjuvant and Metastatic Surgical Considerations
Trevan Fischer, MD
Surgical Oncologist
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate

4:50 PM PT

T cell Therapies
Mark Faries, MD
Director of Surgical Oncology
The Angeles Clinic & Research Institute, A Cedars Sinai Affiliate

5:10 PM PT

First Line Therapies
James Smithy, MD
Medical Oncologist and Cellular Therapist
Memorial Sloan Kettering Cancer Center

5:30 PM PT

Targeted Therapies
Ryan Sullivan, MD
Director
Center for Melanoma
Massachusetts General Hospital

5:50 PM PT

Uveal Melanoma & Rare Melanomas
Inderjit Mehmi, MD
Medical Oncologist
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate

6:10 PM PT

Novel Therapeutics in Melanoma
Omid Hamid, MD
Co-Director of Cutaneous Oncology
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate

6:30 PM PT

AIM at Melanoma Patient Resources
Ann Garst Taylor, CVA
Director Community Engagement
AIM at Melanoma

6:40 PM PT

Q&A & Closing Remarks


REGISTRATION